source
- Moderna launches Phase 3 trial of mRNA bird flu vaccine after US funding cutModerna has begun enrolling participants in a Phase 3 trial of its mRNA-1018 vaccine targeting H5 influenza (bird flu). The trial aims to include about 4,000 healthy adults in the United States and…
- Merck commits up to $1 billion to Google Cloud partnership to accelerate AI across its operationsMerck announced a multiyear partnership with Google Cloud, investing up to $1 billion to embed AI tools throughout its research, development, manufacturing, commercial and corporate functions. The…